An Open-Label Taste Assessment of Tricaprilin Formulated as a Powder for Reconstitution in Healthy Panelists
Phase of Trial: Phase I
Latest Information Update: 08 Nov 2019
Price : $35 *
At a glance
- Drugs Tricaprilin (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Acronyms TMS
- Sponsors Cerecin
- 04 Nov 2019 Status changed from active, no longer recruiting to completed.
- 10 May 2019 Planned End Date changed from 30 Mar 2019 to 30 Sep 2019.
- 10 May 2019 Planned primary completion date changed from 30 Mar 2019 to 30 Sep 2019.